- Home
- VSTM vs HSPO Comparison
VSTM vs HSPO Comparison
Compare VSTM & HSPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- HSPO
- Stock Information
- Founded
- VSTM 2010
- HSPO 2014
- Country
- VSTM United States
- HSPO United States
- Employees
- VSTM N/A
- HSPO N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- HSPO Blank Checks
- Sector
- VSTM Health Care
- HSPO Finance
- Exchange
- VSTM Nasdaq
- HSPO Nasdaq
- Market Cap
- VSTM 132.0M
- HSPO 87.7M
- IPO Year
- VSTM 2012
- HSPO 2022
- Fundamental
- Price
- VSTM $3.88
- HSPO $11.25
- Analyst Decision
- VSTM Strong Buy
- HSPO
- Analyst Count
- VSTM 8
- HSPO 0
- Target Price
- VSTM $14.57
- HSPO N/A
- AVG Volume (30 Days)
- VSTM 1.1M
- HSPO 27.4K
- Earning Date
- VSTM 11-06-2024
- HSPO 01-01-0001
- Dividend Yield
- VSTM N/A
- HSPO N/A
- EPS Growth
- VSTM N/A
- HSPO N/A
- EPS
- VSTM N/A
- HSPO 0.33
- Revenue
- VSTM $10,000,000.00
- HSPO N/A
- Revenue This Year
- VSTM N/A
- HSPO N/A
- Revenue Next Year
- VSTM $125.69
- HSPO N/A
- P/E Ratio
- VSTM N/A
- HSPO $34.26
- Revenue Growth
- VSTM N/A
- HSPO N/A
- 52 Week Low
- VSTM $2.10
- HSPO $10.60
- 52 Week High
- VSTM $14.22
- HSPO $11.25
- Technical
- Relative Strength Index (RSI)
- VSTM 63.77
- HSPO 69.42
- Support Level
- VSTM $3.11
- HSPO $11.17
- Resistance Level
- VSTM $3.76
- HSPO $11.25
- Average True Range (ATR)
- VSTM 0.33
- HSPO 0.00
- MACD
- VSTM 0.04
- HSPO 0.00
- Stochastic Oscillator
- VSTM 94.26
- HSPO 100.00
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About HSPO Horizon Space Acquisition I Corp.
Horizon Space Acquisition I Corp is a blank check company.